Brochure
12 Oct 2023

Unlock the full potential of your injectable product

PDF 2.9 MB

For over four decades, pharma and biotech companies around the world have relied on us to put their parenteral medications on a path to success. We’re proud to help our customers advance their valuable products with innovative services, cutting-edge technology, and flexible, robust, scalable processes that set our partnership apart.

Content provided by our supplier

Vetter Pharma-Fertigung GmbH & Co. KG

  • DE
  • 2015
    On CPHI since
  • 3
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer

Other Content from Vetter Pharma-Fertigung GmbH & Co. KG (4)

  • News CPHI Podcast Series: How to build a successful CDMO partnership

    The latest in our series for the CPHI Podcast Series focuses on partnerships, specifically those between pharma companies and CDMOs. Expert Christine Fürst from Vetter comments on how to make successful and lasting partnerships in the industry. 
  • News Vetter joins United Nations Global Compact Network

    Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 
  • Webinar Evolution of Syringe Closure Technology: Bridging Experience With Innovation

    This presentation looks at the crucial role of syringe closure systems in the field of prefilled syringes and injection devices, offering scientific insights into container closure development. With extensive experience of legacy closure systems, our company explores the potential of integrating historical knowledge with contemporary development methods to create a novel closure system. This presentation will showcase how efficient development strategies and state-of-the-art methods can be used to create a development program that is based on history, is driven by innovation and adheres to the latest combination product regulations.
  • News CPHI Trend Report - CDMO Opportunities in the Chinese Market

    Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.

Recently Visited